Suppression of the Indirect Pathway of T Cell Reactivity by High Doses of Allopeptide

References

• Lechler R I., Batchelor J R. Restoration of immuno-genicity to passenger cell depleted kidney allografts by the addition of donor strain dendritic cells. J. Exp. Med 1982; 155: 31–41
   PubMed Web of Science ®Google Scholar
• Austyn J M. Antigen uptake and presentation by dendritic leukocytes. Semin. Immunol 1992; 4: 227–236
   Google Scholar
• Larsen C P., Ritchie S C., Pearson T C., Linsley P S., Lowry R P. Functional expression of the costimulatory molecule, B7/BB1, in murine dendritic cell populations. J. Exp. Med 1992; 176: 1215
   PubMedGoogle Scholar
• Baraun M Y., McCormack A., Webb G., Batchelor J R. Mediation of acute but not chronic rejection of incompatible rat kidney grafts by alloreactive CD4 T cells activated by the direct pathway of sensitization. Transplantation 1992; 55: 177–182
   Google Scholar
• Suciu-Foca N., Reed E., D'Agati V D., Ho E., Cohen D J., Benvenisty A I., McCabe R., Brensilver J M., King D W., Hardy M A. Soluble HLA antigens, anti-HLA antibodies and anti-idiotypic antibodies in the circulation of rental transplant recipients. Transplantation 1991; 51: 593–601
   Google Scholar
• Suciu-Foca N., Reed E., Marboe C, Xi Y P., Sun Y K., Ho E., Rose E A., Reemtsma K., King D W. Role of anti-HLA antibodies in heart transplantation. Transplantation 1991; 51: 716–172
   Google Scholar
• Shoskes D A., Wood K J. Indirect presentation of MHC antigens in transplantation. Immunology. Today 1994; 15: 32–38
   PubMedGoogle Scholar
• Bradley J A., Mowat A M., Bolton M. Processed MHC-Class I alloantigen as the stimulus for CD4 + T cell dependent antibody-mediated graft rejection. Immunology. Today 1992; 13: 434–438
   Google Scholar
• Clerici M., Shearer G M. Differential sensitivity of human T helper cell pathways by in vitro exposure to cyclosporin A. J. Immunol 1990; 144: 2480–2485
   Google Scholar
• Via C S., Tsokos G C., Stocks N., Clerici M., Shearer G M. Human in vitro allogeneic responses. Demonstration of three pathways of T helper cell activation. J. Immunol 1990; 144: 2524–2528
   PubMed Web of Science ®Google Scholar
• Fukuzawa M., Shearer G M. Effect of cyclosporin A on T cell immunity. I. Dose dependent suppression of different murine T helper cell pathways. Eur. J. Immunol 1989; 19: 49–56
   PubMed Web of Science ®Google Scholar
• De Koster H S., Anderson D C., Termijtelen A. T cells sensitized to synthetic HLA-DR3 peptide give evidence of continuous presentation of denatured HLA-DR3 molecules by HLA-DP. J. Exp. Med 1989; 169: 1191–1196
   Google Scholar
• Rosloniec E F., Vitez L J., Buus S., Freed J H. MHC class II derived peptides can bind to class II molecules, including self molecules, and prevent antigen presentation. J. Exp. Med 1990; 171: 1419–1430
   PubMedGoogle Scholar
• Agrawal B., Manickasundari M., Fraga D., Singh B. T cells that recognize peptide sequences of self MHC class II molecules exists in syngenetic mice. J. Immunol 1991; 147: 383–390
   PubMed Web of Science ®Google Scholar
• Chen B P., Madrigal A., Parham P. Cytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule. J. Exp. Med 1990; 172: 779–788
   Google Scholar
• Essaket S., Fabron J., De Preval C., Thomsen M. Co-recognition of HLA-A1 and HLA-DPw3 by a human CD4 + alloreactive T lymphocyte clone. J. Exp. Med 1990; 172: 387–390
   PubMed Web of Science ®Google Scholar
• Liu Z., Braunstein N., Suciu-Foca N. T cell recognition of allo-peptides in context of syngeneic MHC. J. Immunol 1992; 148: 35–40
   Google Scholar
• Liu Z., Sun Y K., Xi Y P., Maffei A., Reed E., Harries P E., Suciu-Foca N. Contribution of direct and indirect recognition pathway to T cell alloreactivity. J. Exp. Med 1993; 177: 1643–1650
   PubMed Web of Science ®Google Scholar
• Sherwood R., Brent L., Rayfield L S. Presentation of alloantigens by host cells. Eur. Immunol 1986; 16: 569–574
   PubMedGoogle Scholar
• Benichou G., Takizawa P A., Olson C A., McMillan M., Sercarz E E. Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J. Exp. Med 1992; 175: 305–308
   PubMed Web of Science ®Google Scholar
• Benichou G., Takizawa P A., Ho P T., Killion C C., Olson C A., McMillan M., Sercarz E E. Immunogenicity and tolerogenicity of self-major histocompatibility complex peptides. J. Exp. Med 1990; 72: 1341–1346
   Google Scholar
• Fangmann J., Dalchau R., Fabre J W. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides. J. Exp. Med 1992; 75: 1521–1529
   Google Scholar
• Dalchau R., Fangmann J., Fabre J W. Allorecognition of isolated, denatured chains of class I and class II major histocompatibility complex molecules. Evidence for an important role for indirect allorecognition in transplantation. Eur. J. Immunol 1992; 22: 669–677
   PubMed Web of Science ®Google Scholar
• Parker K E., Dalchau R., Fowler V J., Priestley C A., Carter C A., Fabre J W. Stimulation of CD4+ T lymphocytes by allogeneic MHC peptides presented on autologous antigen-presenting cells. Evidence of the indirect pathway of allorecognition in some strain combinations. Transplantation 1992; 53: 918–924
   Google Scholar
• Sayegh M H., Khoury S J., Hancock W W., Weiner H L., Carpenter C B. Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat. Proc. Natl Acad. Sci. USA 1992; 89: 7762–7766
   PubMed Web of Science ®Google Scholar
• Liu Z., Sun Y K., Xi Y P., Hong B., Harris P E, Reed E., Suciu-Foca N. Limited usage of TCR Vβ genes by allopep-tide specific T cells. J. Immunol 1993; 150: 3180–3186
   Google Scholar
• De Magistris T., Alexander J., Coggeshall M., Altman A., Gaeta F C.A., Grey H M., Sette A. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell 1993; 68: 625–634
   Google Scholar
• Alexander J., Snoke K., Ruppert J., Sidney J., Wall M., Southwood S., Oseroff C, Arrhenius T., Gaeta F C.A., Colon S., Grey H M., Sette A. Functional consequences of engagement of the T cell receptor by low affinity ligands. J. Immunol 1993; 150: 1–7
   PubMed Web of Science ®Google Scholar
• Howell D., Winters S T., Olee T., Powell H D., Carlo D J., Brosstoff S W. Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science 1989; 246: 668–670
   PubMed Web of Science ®Google Scholar
• Vandenbark A A., Hashim G., OfFner H. Immunization with a synthetic T cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Na-ture, 1989: 341541–544
   Google Scholar
• Gaur A., Haspel R., Mayer J P., Fathman C G. Requirement for CD8+ cells in T cell receptor peptide-induced clonal unresponsiveness. Science 1993; 259: 91–95
   PubMed Web of Science ®Google Scholar
• Suzuki G., Kawase Y., Koyasu S., Yahara I., Kobayashi Y., Schwartz R H. Antigen-induced suppression of the proliferative response of T cell clones. J. Immunol 1988; 140: 1359–1365
   PubMedGoogle Scholar
• Critchfield J M., Racke M K., Zuniga-Pflucker J C., Can-Nella B., Raine C S., Goverman J., Lenardo M J. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 1994; 263: 1139–1143
   PubMed Web of Science ®Google Scholar
• Scheirle A., Takacs B., Kremer L., Marin F., Sinigaglia F. Peptide binding to soluble HLA-DR4 molecules produced by insert cells. J. Immunol 1992; 149: 1994–1999
   Google Scholar
• King C L., Nutman T B. IgE and IgG subclass regulation by IL-4 and IFH-γ in human Helminth infections. J. Immunol 1993; 151: 458–465
   PubMed Web of Science ®Google Scholar
• Auffray C., Rougeon F. Purification of mouse immuno-globulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur. J. Biochem 1980; 107: 303–314
   PubMedGoogle Scholar
• Choi G., Kotzin B., Herron L., Callahan J., Marrack P., Kappler J. Interaction of Staphylococcus aureus toxin “super-antigens” with human T cells. Proc. Natl Acad. Sci. USA 1989; 86: 8941–8945
   PubMed Web of Science ®Google Scholar
• Sercarz E E., Lehmann P V., Ametani A., Benichou G., Miller A., Moudgil K. Dominance and crypticity of T cell antigen determinants. Annu. Rev. Immunol 1993; 11: 729–766
   PubMed Web of Science ®Google Scholar
• Parker D C. T cell-dependent B cell activation. Annu. Rev. Immunol 1993; 11: 331–360
   PubMed Web of Science ®Google Scholar
• Hart D N.J., Fabre J W. Demonstration and characterization of la positive dendritic cells in the interstitial connective tissues of rat heart and other tissues, but not brain. J. Exp. Med 1981; 154: 347–361
   PubMedGoogle Scholar
• Milton A D., Spencer S C., Fabre J W. The effects of cyclosporin A on the induction of donor class I and Class II MHC antigens in heart and kidney allografts in the rat. Transplantation (Baltimore) 1986; 42: 337–347
   PubMedGoogle Scholar
• Lee R S., Grusby M J., Glimcher L H., Winn H J., Auchincloss H. Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo. J. Exp. Med 1994; 179: 865–872
   PubMed Web of Science ®Google Scholar
• Benichou G., Fedoseyeva E., Lehmann P V., Olson C A., Geysen H M., McMillan M., Sercarz E E. Limited T cell response to donor MHC peptides during allograft rejection: Implications for selective immune therapy in transplantation. J. Immunol 1994; 153: 938–941
   Google Scholar
• Apple R., Clarke J., Cogswell G., Gammon M E.U., Katz U., Krzych R., Maizels F., Manca F., Miller A., Nasseri S., Oki A., Wilbur W W., Sercarz E E. The causes and consequences of immunodominance at the T cell level. The Immune Response to Structurally Defined Proteins: The Lysozyme Model, S J. Smith-Gill, E E. Sercarz. Adenine Press, Gilderland, NY 1989; 267
   Google Scholar